Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

The European response to the WHO call to eliminate cervical cancer as a public health problem

Arbyn, Marc, Gultekin, Murat, Morice, Philippe, Nieminen, Pekka, Cruickshank, Maggie, Poortmans, Philip, Kelly, Daniel, Poljak, Mario, Bergeron, Christine, Ritchie, David, Schmidt, Dietmar, Kyrgiou, Maria, Van den Bruel, Ann, Bruni, Laia, Basu, Partha, Bray, Freddie and Weiderpass, Elisabete 2021. The European response to the WHO call to eliminate cervical cancer as a public health problem. International Journal of Cancer 149 (2) , pp. 277-284. 10.1002/ijc.33189

PDF - Published Version
Available under License Creative Commons Attribution Non-commercial.

Download (831kB) | Preview


The age‐standardised incidence of cervical cancer in Europe varies widely (between 3 and 25/100000 women‐years) in 2018. HPV vaccine coverage is low in countries with the highest incidence and screening performance is heterogeneous among European countries. A broad group of delegates of scientific professional societies and cancer organisations endorse the principles of the WHO call to eliminate cervical cancer as a public health problem, also in Europe. All European nations should, by 2030, reach at least 90% HPV vaccine coverage among girls by the age of 15 years and also boys, if cost‐effective; they should introduce organised population‐based HPV‐based screening and achieve 70% of screening coverage in the target age group, providing also HPV testing on self‐samples for non‐ or under‐screened women; and to manage 90% of screen‐positive women. To guide member states, a group of scientific professional societies and cancer organisations engage to assist in the roll‐out of a series of concerted evidence‐based actions. European health authorities are requested to mandate a group of experts to develop the third edition of European Guidelines for Quality Assurance of Cervical Cancer prevention based on integrated HPV vaccination and screening and to monitor the progress towards the elimination goal. The occurrence of the COVID‐19 pandemic, having interrupted prevention activities temporarily, should not deviate stakeholders from this ambition. In the immediate post‐epidemic phase, health professionals should focus on high‐risk women and adhere to cost‐effective policies including self‐sampling.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Healthcare Sciences
Additional Information: This is an open access article under the terms of the Creative Commons Attribution-Non Commercial License
Publisher: Wiley
ISSN: 0020-7136
Date of First Compliant Deposit: 13 July 2020
Date of Acceptance: 26 June 2020
Last Modified: 02 Dec 2020 11:57

Actions (repository staff only)

Edit Item Edit Item


Downloads per month over past year

View more statistics